Erythropoietin Receptor Expression Is a Potential Prognostic Factor in Human Lung Adenocarcinoma

Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised concerns about the potential tumor-promoting effects of these drugs. Because the clinical significance of erythropoietin receptor (EPOR) signaling...

詳細記述

保存先:
書誌詳細
主要な著者: Rózsás, Anita, Berta, Judit, Rojkó, Lívia, Horváth, László Z., Keszthelyi, Magdolna, Kenessey, István, László, Viktória, Berger, Walter, Grusch, Michael, Hoda, Mir Alireza, Török, Szilvia, Klepetko, Walter, Rényi-Vámos, Ferenc, Hegedűs, Balázs, Döme, Balázs, Tóvári, József
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2013
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3796497/
https://ncbi.nlm.nih.gov/pubmed/24155958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077459
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料